LNSR - LENSAR, Inc.
IEX Last Trade
8.28
0 0%
Share volume: 340
Last Updated: Fri 27 Dec 2024 07:57:35 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$8.28
0.00
0.00%
Fundamental analysis
7%
Profitability
0%
Dept financing
15%
Liquidity
52%
Performance
1%
Performance
5 Days
-3.24%
1 Month
8.84%
3 Months
88.51%
6 Months
91.10%
1 Year
144.02%
2 Year
210.00%
Key data
Stock price
$8.28
DAY RANGE
$8.28 - $8.73
52 WEEK RANGE
$3.16 - $9.23
52 WEEK CHANGE
$138.46
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Nicholas T. Curtis
Region: US
Website: lensar.com
Employees: 110
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: lensar.com
Employees: 110
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
LENSAR, Inc. focuses on developing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Recent news